When prescribing oral isotretinoin to adolescents, we query them regarding their sexual activity and use of contraception. Often these questions are posed in front of their parent/guardian(s) while completing the iPLEDGE consent form. Patient and parent discomfort is often apparent when we ask these questions. Answers to these questions have become even more pertinent as, in many states, access to an abortion for an unwanted pregnancy while on isotretinoin might be challenging and require travel to another state. Are there ethical issues we need to consider regarding this scenario?
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Clinics in Dermatology
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Publication stageIn Press Accepted Manuscript
Edited by Stephen P. Stone, MD
© 2022 Published by Elsevier Inc.